Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Chronic Postsurgical Pain in Mastectomy
NCT05037123Phase 3Active, not recruiting
- Sponsor
- NYU Langone Health
- Start
- Jan 2022
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in chronic postsurgical pain (CPSP), sponsored by NYU Langone Health. Started Jan 2022; status: active, not recruiting.
02
Drugs
ketamine
03
Conditions
chronic postsurgical pain (CPSP)
Beyond the preview
Go deeper on NCT05037123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05037123.